Frontlight ResearchEarly access
CompletedNo phase
Identification of Oral Lesions Through an Autofluorescence System
Key facts
- Who runs it
- Federico II University
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 200 people enrolled
- Started
- 1 Jun 2023
- Ended
- 1 Oct 2024
- Type of study
- Interventional
- Treatments tested
- Screening examination
- Record updated
- 2 September 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Male and female
- Age ≥ 18 years
- Non-smokers and smokers
Who cannot take part
- Cancer patients
- Patients presenting a histological diagnosis of oral mucosal dysplasia/carcinoma
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the study will be to evaluate the efficacy of a tissue autofluorescence detection system as an aid to clinical screening in identifying lesions of the oral mucosa. The screening process will be performed by 3 clinicians with a different level of experience. Sensitivity and specificity tests will be conducted.
The group in the trial
- Screening examinationTreatment being tested
All patients will undergo a screening examination (with or without GOCCLES ® glasses) by all three operators.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Use of a Tissue Autofluorescence Detection System for Identification of Oral Mucosal Lesions
- Record updated
- 2 September 2026